Latest News

Yale School of Medicine’s Dennis Moledina, MD, has focused his scientific career on finding a biomarker to identify kidney inflammation and injury caused by a reaction to medications, also known as acute interstitial nephritis. In a new study, he hopes to use this biomarker to address acute interstitial nephritis caused by cancer immunotherapy.

The section of cardiovascular medicine recently established the Cardiovascular Medicine Analytics Center (CMAC). The new center provides advanced statistical support focused on the specific needs of cardiovascular medicine research.

The use of computer-aided detection (CADe) for colonoscopies has grown significantly in recent years, including at the West Haven VA. Dennis Shung, MD, PhD, is the first author of a new meta-analysis that found doctors using CADe systems found more adenomas than with standard colonoscopies. Shung is also the co-first author of new draft AGA guidelines on using AI assistance for colonoscopies.

James Farrell, MD, recently published a review on the current state of clinical care and research for pancreatic cysts in the New England Journal of Medicine. We spoke with him about this paper, the state of research around pancreatic cysts, and why he is inspired to learn more about this field.

The COVID-19 pandemic led to a huge uptick in research across disciplines. In the first six months after the pandemic hit, 35,000 publications were indexed in PubMed; by the end of the year that number reached 90,000.

F. Perry Wilson, MD, an associate professor of medicine (nephrology) at Yale School of Medicine, discusses various medications that help relieve the symptoms of the flu and colds.

Yale researchers are developing a machine-learning risk model that uses electronic health record (EHR) data to provide an initial patient assessment based on symptoms rather than where the bleeding is thought to be. In a new paper, they evaluate the machine learning risk model against clinical risk scores to determine the most accurate approach.

F. Perry Wilson, MD, associate professor of medicine (nephrology) at Yale School of Medicine, discusses a study showing that the new weight loss drug also helps people quit smoking.